BioStem Technologies Plans Boca Raton, Florida, Headquarters Operations
12/06/2025
The investment will include the construction of a new headquarters facility, located at Research Park at Florida Atlantic University, which will feature administrative offices, manufacturing, and distribution.
“As we contemplate the long-term vision for BioStem, we anticipate the need to expand our operations in support of the growing demand for our advanced wound care products. Securing land at the Research Park provides the space for a centralized headquarters, access to talent and technology and attractive economic incentives,” said Jason Matuszewski, Chairman and CEO of BioStem Technologies. “While opportunities were presented to us by representatives of other states, we knew from the start that we wanted to remain in South Florida and continue to contribute greatly to the overall growth of the local life science industry. The Research Park location will place us among other technology innovators and in close proximity to a university with leading science and healthcare programs from which we can attract and train our highly specialized workforce. Furthermore, the City of Boca Raton has worked closely with us to understand and enable us to meet our real estate needs.”
To support the project the company will receive up to $300,000 in economic incentives from the City of Boca Raton.
“BioStem Technologies’ growth in Boca Raton highlights the cutting-edge innovation driving Palm Beach County’s life sciences industry,” noted Kelly Smallridge, President and CEO of the Business Development Board of Palm Beach County. “We were proud to work with the City of Boca Raton and the Research Park at Florida Atlantic University to support BioStem’s continued expansion and long-term commitment to the region.”
BioStem Technologies specializes in developing and commercializing regenerative therapies from perinatal (placental) tissues, using their BioRetain® processing to maintain growth factors for advanced wound care and other applications. “The addition of BioStem Technologies to the Research Park’s community of innovation demonstrates the importance of our university research park for successful economic growth and long-term prosperity for South Florida,” added Andrew S. Duffell, president of the Research Park at Florida Atlantic. “The ability to collaborate with peer scientists close-by and to offer training opportunities for students is an essential factor in developing a sustainable MedTech industry here.”
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in advanced wound care, focused on maintaining growth factors and preserving tissue structure.
“We’re thrilled BioStem chose Boca Raton for its headquarters. Our talented workforce, strategic location, and supportive community provide the perfect foundation for their continued success,” said Jessica Del Vecchio, Economic Development Manager of the City of Boca Raton.
Project Announcements
Saronic Technologies Expands St. Mary Parish, Louisiana, Operations
12/05/2025
JGA Space and Defense Expands Huntersville, North Carolina, Operations
12/05/2025
SODECIA-AAPICO Plans Orangeburg, South Carolina, Manufacturing Operations
12/05/2025
France-Based Satys Establishes Melbourne, Florida, Operations
12/05/2025
AstraZeneca Expands Frederick-Gaithersburg Maryland, Manufacturing Operations
11/29/2025
Foxconn Expands Mount Pleasant, Wisconsin, Manufacturing Operations
11/28/2025
Most Read
-
Rethinking Local Governments Through Consolidation and Choice
Q3 2025
-
First Person: Filter King’s Expansion Playbook
Q3 2025
-
Rethinking Auto Site Strategy in the Age of Tariffs and Powertrain Shifts
Q3 2025
-
Lead with Facts, Land the Deal
Q3 2025
-
How Canada Stays Competitive
Q3 2025
-
America’s Aerospace Reboot
Q3 2025
-
The Permit Puzzle and the Path to Groundbreaking
Q3 2025